HomeNews

News
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses

Vaccines
Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

Vaccines
African doctor and malaria vaccine

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

Malaria
Medical Sciences
Research
Vaccines
57-year-old Pam receives her vaccine as part of the Oxford/Liverpool clinical trial of MERS ChAdOx1 vaccine.

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

Health
Medical Sciences
Research
Vaccines
Burkina Faso R21 vaccine regulatory clearance

Oxford R21/Matrix-M™ malaria vaccine receives regulatory clearance for use in Burkina Faso

Health
Malaria
Vaccines
Artist's impression of an HIV virus

African Phase I HIV vaccine trial shows encouraging preliminary results

HIV
Medical Sciences
Research
Vaccines
R21 vaccinations at Tanzania clinical site,Tom Wilkinson, University of Oxford

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Malaria
Medical Sciences
Research
Vaccines
Close up image of a vaccine dose being prepared from a vial. Image credit: Shutterstock.

£12 million investment for Future Vaccines Manufacturing Hub

Funding
Health
Medical Sciences
Research
Science
Vaccines
Professor Teresa Lambe receives the Irish Abroad award from Irish President Michael D. Higgins - photo by Maxwell Photography

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

Awards
Vaccines
Ebola vaccine offers long-lasting immunity

Oxford Ebola vaccine manufactured and shipped in record time by SII

Ebola
Health
Medical Sciences
Vaccines

Pages